VEGFA and neoplasm: Judging by the mechanism of SLT-VEGF action, its efficacy should depend on the contribution of VEGFR-2 overexpressing cells to the survival and growth of primary tumors and metastatic lesions at various stages of tumor development through the course of treatment.